Literature DB >> 26272158

Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.

Benjamin L Woolbright1, Hartmut Jaeschke.   

Abstract

Cholestasis is a common pathological component of numerous liver diseases. The initiating event during cholestatic liver injury is widely believed to be the accumulation of bile acids in hepatocytes and the hepatic parenchyma. As bile acids are considered the primary toxic compounds in the injury, numerous in vitro models of bile acid-induced injury and bile acid-induced changes in gene expression have been developed to attempt to better define cholestasis at a cellular level. This chapter focuses on the establishment of a system for determining the effects of cholestatic concentrations of bile acids on hepatocytes using primary hepatocytes or hepatoma cell lines. Moreover, this chapter addresses significant differences in the response of different species to bile acid exposure and novel information on the relevance of treating hepatocytes with concentrations of specific bile acids.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26272158      PMCID: PMC4765948          DOI: 10.1007/978-1-4939-2074-7_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  49 in total

1.  Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.

Authors:  Jocelyn Trottier; Andrzej Białek; Patrick Caron; Robert J Straka; Jenny Heathcote; Piotr Milkiewicz; Olivier Barbier
Journal:  Dig Liver Dis       Date:  2011-12-09       Impact factor: 4.088

Review 2.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

3.  Short-term feedback regulation of bile salt uptake by bile salts in rodent liver.

Authors:  Stefanie Mühlfeld; Olga Domanova; Thomas Berlage; Claudia Stross; Angelika Helmer; Verena Keitel; Dieter Häussinger; Ralf Kubitz
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

4.  Tauro-β-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential.

Authors:  Gerald Ulrich Denk; Carl Philipp Kleiss; Ralf Wimmer; Timo Vennegeerts; Florian Paul Reiter; Sabine Schulz; Hans Zischka; Christian Rust
Journal:  Biochem Biophys Res Commun       Date:  2012-07-15       Impact factor: 3.575

5.  Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.

Authors:  Jae-Hwi Jang; Andreas Rickenbacher; Bostjan Humar; Achim Weber; Dimitri Aristotle Raptis; Kuno Lehmann; Bruno Stieger; Wolfgang Moritz; Christopher Soll; Panco Georgiev; David Fischer; Endre Laczko; Rolf Graf; Pierre-Alain Clavien
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

6.  Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.

Authors:  Karin Dilger; Simon Hohenester; Ursula Winkler-Budenhofer; Barbara A J Bastiaansen; Frank G Schaap; Christian Rust; Ulrich Beuers
Journal:  J Hepatol       Date:  2012-03-10       Impact factor: 25.083

7.  Nitric oxide mimics transcriptional and post-translational regulation during α-tocopherol cytoprotection against glycochenodeoxycholate-induced cell death in hepatocytes.

Authors:  Raúl González; Adolfo Cruz; Gustavo Ferrín; Pedro López-Cillero; Rubén Fernández-Rodríguez; Javier Briceño; Miguel A Gómez; Sebastián Rufián; Manuel De la Mata; Antonio Martínez-Ruiz; Jose J G Marin; Jordi Muntané
Journal:  J Hepatol       Date:  2010-11-26       Impact factor: 25.083

8.  Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity.

Authors:  Benjamin L Woolbright; Anup Ramachandran; Mitchell R McGill; Hui-min Yan; Mary Lynn Bajt; Matthew R Sharpe; John J Lemasters; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2012-09-25       Impact factor: 4.080

Review 9.  The bile salt export pump (BSEP) in health and disease.

Authors:  Ralf Kubitz; Carola Dröge; Jan Stindt; Katrin Weissenberger; Dieter Häussinger
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-07-12       Impact factor: 2.947

10.  Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity.

Authors:  Monika Szabo; Zsuzsa Veres; Zsolt Baranyai; Ferenc Jakab; Katalin Jemnitz
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  6 in total

Review 1.  Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Gene Expr       Date:  2019-06-28

2.  Cholestasis Differentially Affects Liver Connexins.

Authors:  Axelle Cooreman; Raf Van Campenhout; Sara Crespo Yanguas; Eva Gijbels; Kaat Leroy; Alanah Pieters; Andrés Tabernilla; Pieter Van Brantegem; Pieter Annaert; Bruno Cogliati; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

3.  YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced by Rbpj Deletion.

Authors:  Umesh Tharehalli; Michael Svinarenko; Johann M Kraus; Silke D Kühlwein; Robin Szekely; Ute Kiesle; Annika Scheffold; Thomas F E Barth; Alexander Kleger; Reinhold Schirmbeck; Hans A Kestler; Thomas Seufferlein; Franz Oswald; Sarah-Fee Katz; André Lechel
Journal:  Int J Mol Sci       Date:  2018-11-29       Impact factor: 5.923

4.  Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.

Authors:  Lianne de Haan; Sarah J van der Lely; Anne-Loes K Warps; Quincy Hofsink; Pim B Olthof; Mark J de Keijzer; Daniël A Lionarons; Lionel Mendes-Dias; Bote G Bruinsma; Korkut Uygun; Hartmut Jaeschke; Geoffrey C Farrell; Narci Teoh; Rowan F van Golen; Tiangang Li; Michal Heger
Journal:  J Clin Transl Res       Date:  2018-02-16

5.  Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells.

Authors:  Sophie L Penman; Parveen Sharma; Hélène Aerts; B Kevin Park; Richard J Weaver; Amy E Chadwick
Journal:  Toxicol In Vitro       Date:  2019-07-06       Impact factor: 3.500

Review 6.  Prospect of in vitro Bile Fluids Collection in Improving Cell-Based Assay of Liver Function.

Authors:  Astia Rizki-Safitri; Fumiya Tokito; Masaki Nishikawa; Minoru Tanaka; Kazuya Maeda; Hiroyuki Kusuhara; Yasuyuki Sakai
Journal:  Front Toxicol       Date:  2021-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.